发现O-GlcNAc转移酶抑制剂的发现
Benjamin J Gross1, Brian C Kraybill, Suzanne Walker
1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Journal of the American Chemical Society
|October 20, 2005
概括
研究人员开发了一种新系统来产生大量的O-GlcNAc转移酶 (OGT) 和选试验. 这导致了对OGT的新型小分子抑制剂的发现,有助于O-GlcNAcylation研究.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 化学生物学 化学生物学
背景情况:
- O-GlcNAcylation 是一种关键的翻译后修饰,可以调节真核生物信号通路.
- 开发O-GlcNAc转移酶 (OGT) 的小分子抑制剂对于研究O-GlcNAcylation至关重要.
- 以前的挑战包括OGT表达不佳和缺乏有效的高通量选方法.
研究的目的:
- 开发OGT催化领域的大规模生产的表达系统.
- 建立一种基于光的测定方法,用于识别OGT抑制剂.
- 为了发现新型小分子抑制剂的OGT.
主要方法:
- 设计了一个表达系统,以产生大量的OGT催化域.
- 实施了基于光的基质模拟位移试验.
- 选化合物库以识别OGT抑制剂.
主要成果:
- 成功地生产了大量的OGT催化领域.
- 开发并验证了OGT活动的高通量选试验.
- 确定了一组新的小分子OGT抑制剂.
结论:
- 开发的表达系统和检测方法有助于发现OGT抑制剂.
- 这些发现为OGT的结构和功能研究提供了基础.
- 已识别的抑制剂是研究O-GlcNAcylation的宝贵工具.
相关概念视频
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Drug Discovery: Overview
12.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.0K
Dipeptidyl Peptidase 4 Inhibitors
718
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
718
Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
608
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
608
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.6K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K


